Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2016, Article ID 8790120, 5 pages
http://dx.doi.org/10.1155/2016/8790120
Research Article

Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix

1Department of Pathology, College of Medicine, Omdurman Islamic University, 382 Omdurman, Sudan
2Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraidah 6666, Saudi Arabia
3Department of Histopathology and Cytology, College of Medical Laboratories Science, University of Sciences and Technology, Omdurman, Sudan
4College of Veterinary Medicine, Suez Canal University, Ismailia, Egypt

Received 11 November 2015; Revised 19 January 2016; Accepted 14 February 2016

Academic Editor: W. T. Creasman

Copyright © 2016 Nazik Elmalaika O. S. Husain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. zur Hausen, “Human papillomaviruses in the pathogenesis of anogenital cancer,” Virology, vol. 184, no. 1, pp. 9–13, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Waggoner, “Cervical cancer,” The Lancet, vol. 361, no. 9376, pp. 2217–2225, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Y. Babiker, F. M. Eltom, M. S. Abdalaziz, A. Rahmani, S. Abusail, and H. Gadelkareem Ahmed, “Screening for high risk human papilloma virus (HR-HPV) subtypes, among sudanese patients with oral lesions,” International Journal of Clinical and Experimental Medicine, vol. 6, no. 4, pp. 275–281, 2013. View at Google Scholar · View at Scopus
  4. A. H. Rahmani, M. Alzohairy, A. Y. Babiker, A. A. Khan, S. M. Aly, and M. A. Rizvi, “Implication of androgen receptor in urinary bladder cancer: a critical mini review,” International Journal of Molecular Epidemiology and Genetics, vol. 4, no. 3, pp. 150–155, 2013. View at Google Scholar · View at Scopus
  5. N. Kanaji, S. Bandoh, J. Fujita, T. Ishii, T. Ishida, and A. Kubo, “Compensation of type I and type II cytokeratin pools in lung cancer,” Lung Cancer, vol. 55, no. 3, pp. 295–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Azumi and H. Battifora, “The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms: a comprehensive immunohistochemical formalin- and alcohol-fixed tumors,” American Journal of Clinical Pathology, vol. 88, no. 3, pp. 286–296, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. M. I. Kokkinos, R. Wafai, M. K. Wong, D. F. Newgreen, E. W. Thompson, and M. Waltham, “Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo,” Cells Tissues Organs, vol. 185, no. 1–3, pp. 191–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. Vernon and C. LaBonne, “Tumor metastasis: a new twist on epithelial-mesenchymal transitions,” Current Biology, vol. 14, no. 17, pp. R719–R721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Santini, C. Ceccarelli, M. Taffurelli, S. Pileri, and D. Marrano, “Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression,” Journal of Pathology, vol. 179, no. 4, pp. 386–391, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Domagala, J. Lasota, J. Bartkowiak, K. Weber, and M. Osborn, “Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction,” American Journal of Pathology, vol. 136, no. 1, pp. 219–227, 1990. View at Google Scholar · View at Scopus
  11. F. C. S. Ramaekers, D. Haag, A. Kant, O. Moesker, P. H. Jap, and G. P. Vooijs, “Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 9, pp. 2618–2622, 1983. View at Publisher · View at Google Scholar · View at Scopus
  12. V. C. de Araujo, D. S. Pinto Jr., S. O. M. de Sousa, F. D. Nunes, and N. S. de Araujo, “Vimentin in oral squamous cell carcinoma,” European Archives of Oto-Rhino-Laryngology, vol. 250, no. 2, pp. 105–109, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Rahmani, M. Alzohairy, H. Khadri, A. K. Mandal, and M. A. Rizvi, “Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke,” International Journal of Clinical and Experimental Pathology, vol. 5, no. 3, pp. 195–202, 2012. View at Google Scholar · View at Scopus
  14. D. Pradhan, N. Kakkar, A. Bal, S. K. Singh, and K. Joshi, “Sub-typing of renal cell tumours; contribution of ancillary techniques,” Diagnostic Pathology, vol. 4, article 21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. http://www.dako.com/dist/ar38/p106300/prod_products.htm.
  16. M. J. C. Hendrix, E. A. Seftor, R. E. B. Seftor, and K. T. Trevor, “Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior,” The American Journal of Pathology, vol. 150, no. 2, pp. 483–495, 1997. View at Google Scholar · View at Scopus
  17. L. McInroy and A. Määttä, “Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion,” Biochemical and Biophysical Research Communications, vol. 360, no. 1, pp. 109–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Satelli and S. Li, “Vimentin in cancer and its potential as a molecular target for cancer therapy,” Cellular and Molecular Life Sciences, vol. 68, no. 18, pp. 3033–3046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Al-Saad, K. Al-Shibli, T. Donnem, M. Persson, R. M. Bremnes, and L.-T. Busund, “The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer,” British Journal of Cancer, vol. 99, no. 9, pp. 1476–1483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-A. Van der Velden, H. E. Schaafsma, J. J. Manni, D. J. Ruiter, F. C. S. Ramaekers, and W. Kuijpers, “Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx,” European Archives of Oto-Rhino-Laryngology, vol. 254, no. 8, pp. 376–383, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Dauphin, C. Barbe, S. Lemaire et al., “Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas,” Lung Cancer, vol. 81, no. 1, pp. 117–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Hemalatha, T. N. Suresh, and M. L. Harendra Kumar, “Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters,” Indian Journal of Cancer, vol. 50, no. 3, pp. 189–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Gilles, M. Polette, J. Piette et al., “Vimentin expression in cervical carcinomas: association with invasive and migratory potential,” Journal of Pathology, vol. 180, no. 2, pp. 175–180, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Cheng, Y. Zhou, W. Jiang et al., “Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma,” Human Pathology, vol. 43, no. 8, pp. 1213–1220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. U. Kusinska, R. Kordek, E. Pluciennik, A. K. Bednarek, J. H. Piekarski, and P. Potemski, “Does vimentin help to delineate the so-called ‘basal type breast cancer’?” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Abd El-Rehim, S. E. Pinder, C. E. Paish et al., “Expression of luminal and basal cytokeratins in human breast carcinoma,” Journal of Pathology, vol. 203, no. 2, pp. 661–671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. U. Cheang, D. Voduc, C. Bajdik et al., “Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype,” Clinical Cancer Research, vol. 14, no. 5, pp. 1368–1376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Kitamura, T. Toyoshima, H. Tanaka et al., “Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 8, pp. 1299–1310, 2012. View at Publisher · View at Google Scholar · View at Scopus